TMS treatment to reduce voices in schizophrenia
Part of Brain & nervous system, Mental health clinical trials.
This trial studies whether repeated noninvasive brain stimulation (TMS) can help reduce ongoing voice-hearing (auditory verbal hallucinations) in people with schizophrenia or schizoaffective disorder. It focuses on whether doing this after medication is already adjusted can improve symptoms and help keep them controlled.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have schizophrenia or schizoaffective disorder (as diagnosed by DSM-5)
- You take at least one antipsychotic medicine
- You still hear voices despite optimized antipsychotic medicine for at least 6 weeks
- Your medication dose has been stable for at least 6 weeks
- You can speak French and agree to follow the visit schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a non-invasive brain stimulation method called transcranial magnetic stimulation (TMS) can reduce stubborn auditory hallucinations (hearing voices) in people with schizophrenia who haven't improved enough with medication.
This trial tests a brain stimulation treatment (rTMS) to help reduce the frequency and intensity of voices people with schizophrenia hear. It is for individuals who continue to hear voices frequently despite trying multiple medications.
This trial tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help reduce negative symptoms of schizophrenia like lack of motivation or social withdrawal. It might be an option if your negative symptoms are more prominent than positive ones.
This trial tests a targeted brain stimulation method (rTMS) using brain imaging to treat persistent auditory hallucinations that haven't improved with medication. It may help people with schizophrenia who continue to hear voices despite trying multiple antipsychotics.
This study tests a specific brain stimulation approach (TMS) to help reduce auditory hallucinations in adults with schizophrenia who have not improved enough with medications. It may help by changing how the brain regions involved in hearing voices are stimulated.
This study uses a non-invasive brain stimulation method (TMS) along with brain scans (MRI) to better understand why hallucinations happen in schizophrenia. It may help researchers learn more about brain processes involved, which could guide future treatments.
Hear when a new Schizophrenia; Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.